Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study

Table 3 Decrease in minimum plasma glucose levels

Minimum plasma glucose	Repaglinide and clopidogrel group	Mitiglinide and clopidogrel group	Repaglinide group
Minimum plasma glucose	(N = 15)	(N = 15)	(N = 15)
Before starting glinide	145.2 ± 42.9	133.5 ± 33.5	113.6 ± 23.5
After starting glinide	93.3 ± 36.3	131.4 ± 42.9	98.1 ± 21.8
Decrease in minimum levels	51.9 ± 47.5 *	2.1 ± 29.1	15.5 ± 20.0

Mean ± S.D., * p < 0.05 for the “repaglinide and clopidogrel group” versus the “mitiglinide and clopidogrel group”, and the “repaglinide and clopidogrel group” versus the “repaglinide group”

ISSN: 2055-0294